Biodesix, Inc. (NASDAQ:BDSX) Q3 2025 Earnings Call Transcript
Christopher Brinzey: Thank you, operator, and good afternoon, everyone. Today, Biodesix released results from the third quarter of 2025.
Biodesix Inc (BDSX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Birchview Capital Matthew Strobeck | 286,804 | $2,165,370 | -1% | 1.63% |
| 2. | Perceptive Advisors Joseph Edelman | 108,694 | $820,639 | 0.02% | |
| 3. | SilverArc Capital Devesh Gandhi | 49,607 | $374,533 | 0.05% | |
| 4. | Balyasny Asset Management Dmitry Balyasny | 43,024 | $324,831 | 0% | |
| 5. | Millennium Management Israel Englander | 14,944 | $112,827 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.96 | 82,465 | $903,560.76 | 1,463,210 | 2026-01-22 | Filing | |
| $7.04 | 142,045 | $999,996.80 | 1,380,745 | 2025-09-19 | Filing | |
| $6.17 | 3,056 | $18,853.99 | 1,238,700 | 2025-09-18 | Filing | |
| $6.04 | 15,317 | $92,571.35 | 1,235,644 | 2025-09-17 | Filing | |
| $0.43 | 3,488,372 | $1,499,999.96 | 24,406,546 | 2025-08-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.15 | 83 | $676.39 | 1,072 | 2026-01-16 | Filing | |
| $8.15 | 298 | $2,428.49 | 8,446 | 2026-01-16 | Filing | |
| $8.15 | 298 | $2,428.49 | 7,869 | 2026-01-16 | Filing | |
| $8.15 | 970 | $7,904.82 | 38,974 | 2026-01-16 | Filing | |
| $8.15 | 298 | $2,428.49 | 13,654 | 2026-01-16 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 262,425 | $1,784,490 | 0% | |
| 2. | 171 | $1,163 | 0% |
News See All
Biodesix, Inc. (NASDAQ:BDSX) Q2 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Biodesix Q2 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
Biodesix, APAPP Partner to Launch First CME-Accredited Education Program for Lung Cancer Biomarkers
Biodesix Inc. (NASDAQ:BDSX) is one of the best penny stocks under $1 to buy now. On June 10, Biodesix announced a new partnership with the Association of Pulmonary Advanced Practice Providers/APAPP.
12 Best Penny Stocks Under $1 to Buy Now
On July 18, Greg Tuorto of Goldman Sachs joined CNBC's 'Closing Bell' to state that the small-cap market is starting to show signs of life.
Biodesix, Inc. (NASDAQ:BDSX) Q1 2025 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Biodesix's Q1 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Biodesix, Inc. (NASDAQ:BDSX) Q4 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Biodesix, Inc. Q4 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
12 Penny Stocks with Insider Buying in 2025
Insider trading can be a reliable signal for gauging the degree of confidence that management has in the future of their company.
Biodesix, Inc. (NASDAQ:BDSX) Q3 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to Biodesix, Inc. Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Biodesix, Inc. (NASDAQ:BDSX) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Biodesix Q2 2024 Earnings Conference Call. [Operator Instructions]. I would now like to hand the conference over to your speaker today.
Biodesix, Inc. (NASDAQ:BDSX) Q1 2024 Earnings Call Transcript
Operator: Welcome to the Biodesix Q1 2024 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
Hedge Fund Resource Center Billionaire Hedge Funds
